VAERS reports by lot

GSK Varicella/Shingles lot 924T3: VAERS reports

29 VAERS reports list lot 924T3 as a GSK Varicella/Shingles vaccine, received between 2020-06-29 and 2022-08-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
29
Reports
3%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)2329%
Neurological1620%
Injection-site / Local reaction1114%
Dermatological (non-injection-site)911%
Musculoskeletal810%
Gastrointestinal79%
Respiratory34%
Cardiac / Cardiovascular11%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 10).

Pennsylvania9
Ohio7
South Carolina3
Maryland2
Michigan2
California2
Oregon1
Maine1
Washington1
New York1

Reports by month received

2020-061
2020-073
2020-094
2020-112
2020-122
2021-031
2021-051
2021-081
2021-091
2021-102
2021-113
2022-023
2022-033
2022-071
2022-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.